Johnson & Johnson
Kimberly-Clark to buy Tylenol maker Kenvue for over $40 billion
Kimberly-Clark would be scooping up the former Johnson & Johnson unit after months of struggle.
Eyewear as jewelry and a fragrance campaign inspired by desert blossoms
Exotic recovery experience: New hair care brand comes to Israel
COVID-19 booster shots are crucial, according to a Yale study
Booster may be needed for J&J shot as Delta variant spreads - opinion
The CDC is not recommending boosters, and advisors to the agency said at a public meeting this week there is not yet significant evidence of declining protection from the vaccines.
EU clears Pfizer-BioNTech COVID-19 vaccine for adolescents
The decision comes after European Medicines Agency (EMA) backed the use of the vaccine in 12- to 15-year olds earlier in the day
US to resume use of J&J COVID-19 vaccine immediately - FDA, CDC
"The benefits do clearly outweigh the risk from a population and individual perspective."
COVID: Woman hospitalized after J&J vaccine with symptoms like clot cases
A woman in Texas who received Johnson & Johnson's COVID-19 vaccine has been hospitalized after showing symptoms similar to those of six people who recently suffered blood clots.
COVID-19: US CDC to weigh rare clot risk with J&J vaccine as use paused
J&J's single-dose shot is less widely used in the United States compared to the 185 million doses delivered of Moderna and Pfizer/BioNTech's two-shot vaccines.
US calls for pause to J&J COVID-19 vaccine over rare blood clots
The CDC and FDA said the adverse events appeared to be extremely rare.
Fauci: Israeli COVID-19 study misleading on vaccine effectiveness
Fauci explained that the while the S. African variant can break through the vaccines, they are still effective at preventing serious illness and death.
J&J COVID-19 vaccine under EU review over blood clots
The report from the European Medicines Agency is the first to mention a probe of blood clots associated with the J&J vaccine.
Coronavirus: US puts J&J in charge, removes AstraZeneca from faulty plant
The government’s move to have the facility make only the J&J single-dose vaccine is meant to avoid future mix-ups.
Johnson & Johnson finds issue with COVID vaccine batch, 15m. doses ruined
J&J did not say how many vaccine doses the batch would have produced. The New York Times reported that about 15 million doses were ruined, without citing a source.